PROCEPT BioRobotics Corporation (PRCT) financial statements (2022 and earlier)

Company profile

Business Address 900 ISLAND DRIVE
REDWOOD CITY, CA 94065
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments304,320320,484
Cash and cash equivalents304,320320,484
Restricted cash and investments777777
Receivables4,4646,353
Inventory, net of allowances, customer advances and progress billings13,14710,401
Inventory13,14710,401
Prepaid expense2,9841,342
Other undisclosed current assets481113
Total current assets:326,173339,470
Noncurrent Assets
Operating lease, right-of-use asset3,2793,667
Property, plant and equipment5,0455,731
Intangible assets, net (including goodwill), including:1,7501,818
Intangible assets, net (excluding goodwill)(800)(700)
Other undisclosed intangible assets, net (including goodwill)2,5502,518
Restricted cash and investments777777
Total noncurrent assets:10,85111,993
TOTAL ASSETS:337,024351,463
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities8,5048,465
Accounts payable2,0293,590
Employee-related liabilities6,4754,875
Deferred revenue1,025848
Other liabilities4,6082,834
Other undisclosed current liabilities2,1052,032
Total current liabilities:16,24214,179
Noncurrent Liabilities
Long-term debt and lease obligation51,99552,312
Long-term debt, excluding current maturities50,00449,762
Operating lease, liability1,9912,550
Liabilities, other than long-term debt1,6961,660
Other liabilities200200
Derivative instruments and hedges, liabilities1,4961,460
Total noncurrent liabilities:53,69153,972
Total liabilities:69,93368,151
Stockholders' equity
Stockholders' equity attributable to parent267,091283,312
Additional paid in capital528,666526,526
Accumulated other comprehensive loss(54)(41)
Accumulated deficit(261,521)(243,173)
Total stockholders' equity:267,091283,312
TOTAL LIABILITIES AND EQUITY:337,024351,463

Income statement (P&L) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
Revenues10,1388,668
Cost of revenue(5,622)(4,428)
Gross profit:4,5164,240
Operating expenses(21,347)(17,037)
Operating loss:(16,831)(12,797)
Nonoperating income (expense)(63)147
Investment income, nonoperating4199
Other nonoperating expense(67)(52)
Interest and debt expense(1,440)(1,469)
Net loss:(18,334)(14,119)
Other undisclosed net income (loss) attributable to parent(14)16
Net loss available to common stockholders, diluted:(18,348)(14,103)

Comprehensive Income ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
Net loss:(18,334)(14,119)
Comprehensive loss:(18,334)(14,119)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(27)14
Comprehensive loss, net of tax, attributable to parent:(18,361)(14,105)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: